A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).
Clinical trial NCT04912869 · COMPLETED
Trial details
- NCT number
- NCT04912869
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-26
- Primary completion
- 2024-12-23
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.